81 results
Categories
Human Remove Human filter
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Medicine type
Exceptional circumstances Remove Exceptional circumstances filter
Biosimilar Remove Biosimilar filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Retacrit (updated)
Date of authorisation: 18/12/2007,
, Revision: 25, Authorised, Last updated: 14/01/2020
-
List item
Human medicine European public assessment report (EPAR): Trazimera (updated)
Date of authorisation: 26/07/2018,
, , Revision: 4, Authorised, Last updated: 14/01/2020
-
List item
Human medicine European public assessment report (EPAR): Scenesse (updated)
Date of authorisation: 22/12/2014,, 
, 
, Revision: 6, Authorised, Last updated: 14/01/2020
-
List item
Human medicine European public assessment report (EPAR): Ziextenzo (updated)
Date of authorisation: 22/11/2018,, , Revision: 2, Authorised, Last updated: 13/01/2020
-
List item
Human medicine European public assessment report (EPAR): Riximyo (updated)
Date of authorisation: 15/06/2017,, , Revision: 4, Authorised, Last updated: 13/01/2020
-
List item
Human medicine European public assessment report (EPAR): Blitzima (updated)
Date of authorisation: 13/07/2017,, , Revision: 8, Authorised, Last updated: 13/01/2020
-
List item
Human medicine European public assessment report (EPAR): Inflectra (updated)
Date of authorisation: 09/09/2013,, Revision: 24, Authorised, Last updated: 09/01/2020
-
List item
Human medicine European public assessment report (EPAR): Nivestim (updated)
Date of authorisation: 07/06/2010,, Revision: 21, Authorised, Last updated: 09/01/2020
-
List item
Human medicine European public assessment report (EPAR): Inhixa (updated)
Date of authorisation: 15/09/2016,, , Revision: 12, Authorised, Last updated: 09/01/2020
-
List item
Human medicine European public assessment report (EPAR): Flixabi (updated)
Date of authorisation: 26/05/2016,, , Revision: 11, Authorised, Last updated: 07/01/2020
-
List item
Human medicine European public assessment report (EPAR): Remsima (updated)
Date of authorisation: 10/09/2013,, Revision: 17, Authorised, Last updated: 06/01/2020
-
List item
Human medicine European public assessment report (EPAR): Kolbam (updated)
Date of authorisation: 20/11/2015,, , , Revision: 13, Authorised, Last updated: 20/12/2019
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)
Date of authorisation: 08/05/2017,, , , Revision: 7, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone
Date of authorisation: 08/09/2015,, , , Revision: 5, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Foclivia
Date of authorisation: 18/10/2009,, Revision: 9, Authorised, Last updated: 04/12/2019
-
List item
Human medicine European public assessment report (EPAR): Mepsevii
Date of authorisation: 23/08/2018,, , , Revision: 3, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Strensiq
Date of authorisation: 28/08/2015,, , , Revision: 10, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Udenyca
Date of authorisation: 21/09/2018,, , Revision: 3, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Kanjinti
Date of authorisation: 16/05/2018,, , Revision: 6, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Vyndaqel
Date of authorisation: 16/11/2011,, , , Revision: 15, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Pelgraz
Date of authorisation: 21/09/2018,, , Revision: 4, Authorised, Last updated: 28/11/2019
-
List item
Human medicine European public assessment report (EPAR): Rixathon
Date of authorisation: 15/06/2017,, , Revision: 3, Authorised, Last updated: 28/11/2019
-
List item
Human medicine European public assessment report (EPAR): Atriance
Date of authorisation: 22/08/2007,, , , Revision: 21, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Elaprase
Date of authorisation: 08/01/2007,, , , Revision: 19, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Erelzi
Date of authorisation: 23/06/2017,, , Revision: 5, Authorised, Last updated: 21/11/2019